Optimizing the opportunity for female fertility preservation in a limited time-frame for patients with cancer using in vitro maturation and ovarian tissue cryopreservation
Increasingly patients are seeking the advice of reproductive medicine clinicians and scientists to enable them to preserve their gametes and/or embryos. The reasons are either as a form of reproductive insurance, or more important, to preserve their fertility before undergoing gonadotoxic therapy, most commonly chemotherapy. It is a guideline of the American Society of Clinical Oncology that all health care providers caring for adult and pediatric patients with cancer should address the possibility of infertility as early as possible before treatment starts (1).
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Roger J. Hart Tags: Reflections Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Health Management | Infertility | Insurance | Ovarian Cancer | Ovaries | Pediatrics | Reproduction Medicine